Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Anyone remember the CA wildfires and their effect on the SHM one year?

Suppose they are planning on selling the MMP. How would all vote on that issue?

"Additional considerations were given to PTSC's expected improved traction in the justice and public safety markets, and the excellent results of the recent CDX technology evaluation which included the reassessment of CDX as a core driver for maximizing shareholder value."

Seems that the recent focus is on the CDX product line with little mention of the MMP. although they did say "a core driver", and not "the core driver" very big difference. Every fasciate of the PR's always have to analyzed. Wouldn't it be great if one day we did not have to read between the lines all the time?

Share
New Message
Please login to post a reply